NRGP

Date Particulars Department Initiated by
10/1/2019 NGP:ORB1920-NR-0699 AR OPHTHALMIC Ankitha

10/1/2019 NGP:ORB1920-NR-0701 AR COMPLEX Bala Krishna
10/1/2019 NGP:ORB1920-NR-0703 FR COMPLEX Mahesh S
10/1/2019 NGP:ORB1920-NR-0705 AR OPHTHALMIC Satish Babu
10/3/2019 NGP:ORB1920-NR-0710 FR COMPLEX Mahesh S
10/3/2019 NGP:ORB1920-NR-0711 PACKING Rajendhar
10/3/2019 NGP:ORB1920-NR-0714 FR OPHTHALMIC Gangadhar G
10/4/2019 NGP:ORB1920-NR-0719 FR OPHTHALMIC Satish Kumar
10/10/2019 NGP:ORB1920-NR-0723 AR COMPLEX Murthy R
10/12/2019 NGP:ORB1920-NR-0729 AR COMPLEX Syamala
10/12/2019 NGP:ORB1920-NR-0732 AR COMPLEX Prasanth
10/12/2019 NGP:ORB1920-NR-0734 AR COMPLEX Prasanth
10/15/2019 NGP:ORB1920-NR-0746 FR OPHTHALMIC Yeshwanth T
10/18/2019 NGP:ORB1920-NR-0759 AR COMPLEX Raghvendra
10/21/2019 NGP:ORB1920-NR-0772 FR OPHTHALMIC Sivananda Reddy D
10/28/2019 NGP:ORB1920-NR-0800 AR COMPLEX Jagadesh Kumar
10/30/2019 NGP:ORB1920-NR-0802 AR INJECTABLE Ankitha
Party Name
Invitron Advanced Analytics Pvt. Ltd
Analys Labs Pvt Ltd
Analys Labs Pvt Ltd
Analys Labs Pvt Ltd
Food And Drug Administration
Daicel Chiral Technologies (India) Pvt Ltd
Biological E.Limited, Pharma Division
Topical Products Testing LLC
Teena Biolabs Pvt Ltd
Alembic Pharma(Creditors)
Presque Isle Testing Labs
Legend Pharma Technologies
OBVEZ Labs Pvt Ltd
Gland Pharma Limited
Berry Global Inc
Laxai Life Sciences Pvt Ltd
O
Project Name
Bromfenac Ophthalmic Solution USP, 0.07%
Triamcinolone Acetonide Suspension (10mg/mL & 40mg/mL)
Triamcinolone Acetonide Suspension (10mg/mL & 40mg/mL)
Liraglutide Injection 18mg/3mL (6mg/mL)
Cyclosporine Ophthalmic Emulsion 0.05%
Brimonidine Tartrate Ophthalmic Solution 0.1%
Teriparatide Injection 600 Mcg/2.4mL(250 Mcg/mL)
Brinzolamide Oph Suspension 1%
Bepotastine Besilate Ophthalmic Solution 1.5%
NA-Complex
Loteprednol Ophthalmic Suspension 0.2%
Loteprednol Etabonate Ophthalmic Gel 0.5%
NA-Opthlmic
NA-Opthlmic
NA-Opthlmic
NA-Opthlmic
NA-Opthlmic
NA-Opthlmic
NA-Opthlmic
Triamcinolone Acetonide Injectable Suspension 40mg/mL
Timolol GFS EQ 0.25% Base EQ 0.5% Base
Azithromycin Oph. Solution 1%
Ciprofloxacin+ Dexamethasone 0.3% ; 0.1%
Ciprofloxacin+ Dexamethasone 0.3% ; 0.1%
Tobramycin + Dexamethasone Ophthalmic Suspension 0.3/0.1%
Difluprednate Ophthalmic Emulsion 0.05%
NA-Opthlmic
NA-Opthlmic
NA-Opthlmic
NA-Opthlmic
NA-Opthlmic
Paliperidone Nano Suspen. 1M (39mg,78mg,117mg,156mg,234mg)
Brimonidine + Timolol Ophthalmic Solution 0.2% EQ 0.5% BASE
Olopatadine HCl Oph Soln USP, 0.7%
Paclitaxel NAB 100mg
Bendamustine HCL Injection 25mg/ml
Exentide Extended Release For Inj Susp 2mg
Octreotide Microsphere 1M (10mg, 20mg, 30mg)
Paliperidone Nano Suspension 3M (273mg,410mg,546mg,819mg)
Tigecycline FOI USP 50 Mg/vial
Orbicular Pharmaceutical Technologies Pvt Ltd.
NRGP Register 01-10-2019 To 02-11-2019
Project=COMPLEX
Category
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
PACKING MATERIAL
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
API
Finished Products
CAPEX
SERVICE/OUTSOURCING
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
API
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
STANDARDS & IMPURITY
SERVICE/OUTSOURCING
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
CHEMICALS/REAGENTS/SOLVENTS
CONSUMABLES
RLD/INNOVATORS
RLD/INNOVATORS
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
PACKING MATERIAL
Finished Products
Finished Products
RLD/INNOVATORS
Finished Products
Finished Products
RLD/INNOVATORS
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
Finished Products
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
SERVICE/OUTSOURCING
Finished Products
API
API
RLD/INNOVATORS
RLD/INNOVATORS
RLD/INNOVATORS
API
Orbicular Pharmaceutical Technologies Pvt Ltd.
NRGP Register 01-10-2019 To 02-11-2019
Project=COMPLEX
Particulars Units Quantity

Bromfenac Ophthalmic Solution USP, 0.07% MLT 5.000
Triamcinolone Acetonide Injectable Suspension 40mg/mL NOS 132.000
Triamcinolone Acetonide Injectable Suspension 40mg/mL NOS 25.000
Liraglutide Injection In-house Kit Pack NOS 1.000
Cyclosporine Ophthalmic Emulsion 0.05% MLT 10.000
Brimonidine Tartrate Ophthalmic Solution 0.1% MLT 15.000
Brimonidine Tartrate Ophthalmic Solution 0.15% NOS 15.000
Brimonidine Tartrate Ophthalmic Solution 0.15% NOS 30.000
Fixed Dosepen(Teriparatide)Shaily Eng NOS 5.000
Plain Carton Reverse Tuck In Style 187X34X77mm/Pragati NOS 20,184.000
Plain Carton Reverse Tuck In Style 20X20X68mm/Pragati NOS 16,650.000
Plain Carton With Bottom Lock Style 225X115X75mm/Pragati NOS 350.000
Brinzolamide USP USP/Icrom S.P.A Italy GMS 2.000
Bepotastine Besilate Ophthalmic Solution 1.5% NOS 5.000
Pen Device UV Gluing Applicator/assembling Equipment-Shaily NOS 1.000
Test/Leuprolide Acetate For Depot Suspension-DSC NOS 3.000
Teriparatide Injection 600 Mcg/2.4 ML (250 Mcg/mL) NOS 3.000
Teriparatide Injection 600 Mcg/2.4 ML (250 Mcg/mL) NOS 3.000
Liraglutide Injection 6mg/mL NOS 1.000
Liraglutide Sodium Salt IH/Poly Peptide Group GMS 0.001
Loteprednol Etabonate Methyl Ester/Farmabios GMS 0.002
1,2 -Dihydrol Loteprednol Etabonate/Farmabios GMS 0.002
1,2-Dihydro Diethyl Carbonate/Farmabios GMS 0.002
Loteprednol Etabonate 11-Keto/Farmabios GMS 0.002
Test/Loteprednol Etabonate Oph Gel 0.5%- D-Value NOS 1.000
5ml White LDPE Rachet Modified Screw Neck Bottle,GS/Bprex NOS 100.000
5ml Natural LDPE Rachet Modified Screw Neck Bottle,GS/Bprex NOS 100.000
45µl White LDPE Nozzle, GS/Rexam NOS 600.000
Blue HDPE Ring Modified Screw Cap,GS /Berry Plastics NOS 300.000
Pink HDPE Ring Modified Screw Cap, GS/Berry Plastics NOS 300.000
Triamcinolone Acetonide EP Impurity A/Synzeal GMS 0.010
Triamcinolone Acetonide EP Impurity B/Synzeal GMS 0.010
Triamcinolone Acetonide EP Impurity C/Synzeal GMS 0.010
Triamcinolone Acetonide EP Impurity E/Synzeal GMS 0.010
Timolol GFS EQ 0.25% Base EQ 0.5% Base NOS 2.000
Azithromycin Oph. Solution 1% NOS 1.000
Acetic Acid/Merck MLT 2.500
Ammonia Solution/Merck MLT 2.500
Acetonitrile/Merck BTL 15.000
Methanol/Merck KLR 37.500
M-Cresol GC Standard/Addchem MLT 100.000
Ortho Phosphoric Acid/Merck MLT 1,500.000
Sodium Sulfate,anhydrous/Alfa Aesar GMS 1,500.000
Sodium Acetate Trihydrate/Merck GMS 1,000.000
Minaral Oil/Addchem KLR 2.000
Piperazine/Sigma Aldrich GMS 100.000
Potassium Hydroxide 45% Solution KLR 2.000
Trifluoroacetic Acid/Alfa Aesar KLR 0.200
Trifluoroacetic Acid/Sigma MLT 2.000
Met+O(18)teriparatide Impurity/Polypeptide GMS 0.002
Met+O(8)teriparatide Impurity/Polypeptide GMS 0.002
Met+O(8,18)teriparatide Impurity/Polypeptide GMS 0.015
(Asp16)-PTH(1-34)/Polypeptide GMS 0.002
PTH(1-31)/Polypeptide GMS 0.002
Glu6-PTH(1-34)/Polypeptide GMS 0.002
Asp33/Polypeptide GMS 0.002
Ac-PTH(1-34)/Polypeptide GMS 0.002
Glu29/Polypeptide GMS 0.002
[D-Asn33]-Teriparatide/Polypeptide GMS 0.002
D-Arg20/Polypeptide GMS 0.002
Parathyroid Hormone(1-34),Human,Acetate (WRS)/PolyPeptide GMS 0.050
[D-Glu4]-Teriparatide/Polypeptide GMS 0.002
Asp10/Polypeptide GMS 0.002
[D-Gln6]-Teriparatide/Polypeptide GMS 0.002
[D-Met18]Teriparatide/Polypeptide GMS 0.002
[D-His14] Teriparatide/Polypeptide GMS 0.002
[Endo-Ser1]-PTH/Polypeptide GMS 0.002
(Asp16)-PTH(1-34)/Polypeptide GMS 0.002
Teriparatide/USP RS GMS 0.002
Liraglutide Vialled Reference Std/Polypeptide GMS 0.030
Pycnometar 10ml/DR Lab NOS 1.000
Prolensa 0.07%3mL Bausch & Lomb NOS 1.000
Prolensa 0.07%3mL Bausch & Lomb NOS 1.000
Ciprofloxacin+ Dexamethasone 0.3% ; 0.1% MLT 100.000
Ciprofloxacin+ Dexamethasone 0.3% ; 0.1% MLT 100.000
Tobramycin + Dexamethasone Ophthalmic Suspension 0.3/0.1% MLT 100.000
Difluprednate Ophthalmic Emulsion 0.05% NOS 1.000
Yellow HDPE Ring Modified Screw Cap,GS/Bprex NOS 25,315.000
45µl White LDPE Nozzle, GS/Rexam NOS 30,315.000
5ml White LDPE Rachet Modified Screw Neck Bottle,GS/Bprex NOS 6,315.000
5ml White LDPE Rachet Modified Screw Neck Bottle,GS/Bprex NOS 19,315.000
30µl White LDPE Nozzle, GS/Berry Plastics NOS 100.000
30µl Natural LDPE Nozzle, GS/Berry Plastics NOS 100.000
30µl White LDPE Nozzle, ETO/Berry Plastics NOS 100.000
30µl Natural LDPE Nozzle, ETO/Berry Plastics NOS 100.000
Natural LDPE Nozzle ETO Sterile (14182)/Gerresheimer NOS 100.000
Paliperidone Palmitate Working Standard/Interquim GMS 1.000
Tobradex 0.3%/0.1%10 ML Alcon NOS 1.000
Tobramycin + Dexamethasone Ophthalmic Suspension 0.3/0.1% NOS 1.000
Brimonidine + Timolol Ophthalmic Solution 0.2% EQ 0.5% BASE MLT 100.000
Endoproteinase Glu-C/Sigma PAC 1.000
Olopatadine/Lavybens GMS 0.100
Sodium Perchlorate Monohydrate/Carlo GMS 250.000
Pacliall 100mg Injection(Panacea Biotec) NOS 1.000
Brimonidine Tartrate Ophthalmic Solution 0.1% MLT 2,600.000
Brimonidine Tartrate Ophthalmic Solution 0.1% MLT 1,500.000
Bendamustine HCL Injection 25mg/ml NOS 1.000
Adventol/Adveny 1.000
Monothioglycerol/simson GMS 5.000
Exenatide Extended Release Inj Susp For Subcutan 2mg/0.85mL NOS 1.000
Teriparatide/USP RS GMS 0.001
Parathyroid Hormone(1-34),Human,Acetate (WRS)/PolyPeptide GMS 0.100
Proton NMR/Octreotide Acetate ER Inj Depo-silicon Oil/Laxai NOS 1.000
Parathyroid Hormone(1-34), Human,Acetate IH/Polypeptide NOS 0.050
Parathyroid Hormone(1-34), Human,Acetate IH/Polypeptide NOS 0.050
BEPREVE 1.5% 10 ML Bausch & Lomb NOS 17.000
Impurity-1 (Paliperidone)/Ferrer GMS 0.015
Impurity-2 (Paliperidone Myristate)/Ferrer GMS 0.015
Impurity-3 (Paliperidone Pentadecanoate)/Ferrer GMS 0.015
Impurity-4 (Paliperidone Heptadecanoate)/Ferrer GMS 0.015
Impurity-5 (Paliperidone Stearate)/Ferrer GMS 0.015
Tigecycline API/Chongqing Kangle MGS 0.100
Ref Batch No Purpose
SB/19/001(25/40-6m(u)) For Sodium sulfite
SB/19/001(25/40-6m(i)) For Sodium sulfite
SB/19/001(25/40-6m(i)) For Quantitative colour test
40307-006-1 Ml FILL FOR AMV of PSD and Viscosity
40309-091-10 mLfill FOR AMV of PSD and Viscosity
NA FDA evaluation purpose
40305-060(End of 14th day) For GSD and Zeta potential
40305-090(100% bulk Initial) For GSD and Zeta potential
40111-020(25/40-3m(i)) For Analysis
40109-021(25/40-12m(i)) For Analysis
40112-004(PSS Dark control) For Analysis
40114-003(7th day in-use sample) For Analysis
NA For Evaluation
For Exhibit bathces
For Exhibit bathces
For Exhibit bathces
022 17M1 for rabbit transcorneal permeation study
SB/19/002 for ICHQ3D method development
For Exhibit batches
40346-027, 40346-029, 1088959 For Glass transition temperature (TG)
40313-019 For MD and Verification-Intact Mass
40313-029 For MD and Verification-Intact Mass
40312-018 25°C-60%RH For Mass study
HS66H31 25°C-60%RH-6M For Mass study
40312-018P 25°C-60%RH-PLACEBO For Mass study
40312-025 25°C 2M For Mass study
PPL-P11901701 For Mass study
40312-023-25°C-3M For Mass study
40109-070B(25/40-3m(i))-pH 7.80 For SOC Analysis
40109-068(30/65-3m(i)) For SOC Analysis
40109-008B(25/40-3m(i)) For SOC Analysis
40109-069A(40/25-3m(u))-pH 7.4 For SOC Analysis
40109-069A(40/25-3m(i))-pH 7.4 For SOC Analysis
40109-070B(40/25-3m(u))-pH 7.80 For SOC Analysis
40109-070A(40/25-3m(u))-pH 7.99 For SOC Analysis
40109-069B(40/25-3m(u))-pH 7.55 For SOC Analysis
40109-067(30/65-6m(u)) For SOC Analysis
40109-067(30/65-6m(i) For SOC Analysis
40109-069B(30/65-3m(i)-pH 7.55 For SOC Analysis
40111-021(40/25-3m(u) For SOC Analysis
40313-025-2-8°C,2M For mass study
RS8.2.15 For Validation
40213-061 D value study
For machine trial purpose
SRL-296-150 For RS AMV Accuracy
SRL-B-42 For RS AMV Accuracy
ANB801 For FDA Query
AMZ801 For FDA Query
180773A For FDA Query
180374 For FDA Query
40118-083 For PET Study
CC9C690219 FOR BE ANALYSIS
DF9D691914 FOR BE ANALYSIS
D19DF69994 FOR BE ANALYSIS
S19SF69873 FOR BE ANALYSIS
F19B014 FOR BE ANALYSIS
CB9C690024 FOR BE ANALYSIS
10222749 FOR BE ANALYSIS
DH8D628156 FOR BE ANALYSIS
F19D341 FOR BE ANALYSIS
STBJ0621 FOR BE ANALYSIS
MKCK8859 FOR BE ANALYSIS
10219117 FOR BE ANALYSIS
BCBX5161 FOR BE ANALYSIS
HF42140 For API method Transfer
HF42138
HF42145
B407130
HF42169
B407368
B409213
B407135
B409214
B407195
B409060
NA
B47160
B408109
B407033
B407030
B407259
HF42168
HF42173B
R08070
PPL-P11901701 Mass identification by LCMS
3583 for weight/ml analysis
Lot no:322321 For Sodium sulfite
Lot no:299571 For Sodium sulfite
40145-123(High particle size) For Dissolution and Discrimination
40145-123(High Viscosity) For Dissolution and Discrimination
40192-125D(High Viscosity) For Dissolution and Discrimination
40192-116(As such) For Dissolution and Discrimination
40192-125C(High Particle size) For Dissolution and Discrimination
40125-084(High GSD) For Dissolution
42572 Media fill
51179 Media fill
52381 Media fill
52666 Media fill
31958 for Extractable Study
2511114G00 for Extractable Study
40109-077 For SOC Analysis(Validation batch)
40109-078(Placebo) For SOC Analysis(Validation batch)
A18097A FOR AMV Pali RS and Disso
275807F(End of Shelf life) For Sodium sulfate
40191-069(25/40-18m(u) For Sodium sulfate
40453-001 For Drop size study
10025184 For Method Verifcation -Peptide Mapping
1810001 For Validation(REM)
V7M535277M FOR API METHOD TRANSFER
901418033 FOR IVRT AMD
40109-077(Product) For Validation
40109-077P(Product placebo) For Validation
40109-078(SOC Placebo) For Validation
40109-080(Boric acid placebo) For Validation
40487-008(Product) For Validation
40487-007(Placebo) For Validation
40487-008A(Placebo for MTG) For Validation
40487-008B(Placebo for Ethanol) For Validation
F16D011 For Validation
SP-021-050 For Validation
40374-081A SILICON OIL CONTENT
40374-089B1 SILICON OIL CONTENT
40374-093 SILICON OIL CONTENT
40374-087A1 SILICON OIL CONTENT
40374-091A2 SILICON OIL CONTENT
40374-093 E SILICON OIL CONTENT
40374-093 F SILICON OIL CONTENT
40374-093 B SILICON OIL CONTENT
40374-093 D SILICON OIL CONTENT
40374-093 C SILICON OIL CONTENT
R08070 For AMT System I API RS
30-19-0128-01 For API AMT AND Peptide Mapping Verfication
40327-139P A (AFTER 1ST WASH) SILICON OIL CONTENT
40327-139P B (AFTER 2nd WASH) SILICON OIL CONTENT
40327-139P C (AFTER 3rd WASH) SILICON OIL CONTENT
40327-139P D (AFTER 4th WASH) SILICON OIL CONTENT
40327-139P E (AFTER 5th WASH) SILICON OIL CONTENT
40327-139P F (AFTER 6th WASH) SILICON OIL CONTENT
40327-140 (AFTER 2 HEPTANE WASH) SILICON OIL CONTENT
40327-140 A3(IN PROCESS SILICON OIL CONTENT
40327-141P A (After 1st wash) SILICON OIL CONTENT
40327-141P B (After 2nd wash) SILICON OIL CONTENT
40327-141P C (After 3rd wash) SILICON OIL CONTENT
40327-141P D (After 4th wash) SILICON OIL CONTENT
40327-141P E (After 5th wash) SILICON OIL CONTENT
40327-141P F (After 6th wash) SILICON OIL CONTENT
40305-062A(25/40-9m(i) Fro GSD Analysis
30-18-0103-01 FOR SYSTEM SUITABLITY PREPARATION
30-18-0101-01 OFR BE QC SYSTEMSUITABLITY
322581 PEQ study
329241 PEQ study
330681 PEQ study
STD-10-20 For AMV RS -3M
TJH-180102 For Mass Identification
Remarks PO No Pending?
NA ORB1920-PO-0900
NA ORB1920-PO-0900
NA ORB1920-PO-0900
NA ORB1920-PO-0900
NA ORB1920-PO-0900
NA ORB1920-PO-0900
NA ORB1920-PO-0903
NA ORB1920-PO-0903
NA ORB1920-PO-0903
FOR AMV of PSD and Viscosity ORB-1920-PO-638
FOR AMV of PSD and Viscosity ORB-1920-PO-638
One Pack contains 2 NO's In-House NA
NA ORB1920-PO-0905,727
NA ORB1920-PO-0905,727
NA na
NA na
NA na
NA na
NIL NA
NA ORB1920-PO-0440
NA ORB1920-PO-0440
NA ORB1920-PO-0440
PDMP preparation NA
NIL As per agreemnet ba
NA NA
FOR Tg ORB1920-PO-0986
For Id by LC MS ORB1920-PO-980 Dinesh
For Id by LC MS ORB1920-PO-980 Dinesh
0.5 mL ORB1819-PO-02326
0.5mL ORB1819-PO-02326
0.5 mL ORB1819-PO-02326
0.5 mL ORB1819-PO-02326
10 mg ORB1819-PO-02326
NA
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
ORB1920-PO-0839
0.5 mL
NA NA
NA NA
NA NA
NA NA
100 grams PO-0894
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
For RS AMV Accuracy ORB1920-PO-0638
ORB1920-PO-0638
ORB1920-PO-0638
ORB1920-PO-0638
Timolol GFS 0.5% NA
Timolol GFS 0.5% NA
Timolol GFS 0.5% NA
Timolol GFS 0.5% NA
Timolol GFS 0.25% NA
Timolol GFS 0.25%(Qty:05ml) NA
Timolol GFS 0.5%(Qty:05ml) NA
Qty:200ml ORB1920-Po-1013
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
ORB1920-PO-0975
02no Vials ORB1920-PO-0975
PPL API ORB1920-PO-02326
for BE NA
Qty:03ml(Initials) ORB1920-PO-1041
Qty:03ml(Initials) ORB1920-PO-1041
NA Agrment no:APL/84/2
Qty:150ml Agrment no:APL/84/2
12 X 2 X 1000 and 1 X 1X1000 ORB1920-PO-0908
3 X 3 X 3000 and 1 X 1 X 1000 ORB1920-PO-0908
2 X 6 X 500 ORB1920-PO-0908
6 X 6 X 500 and 1 X 2 X 500 (inclu ORB1920-PO-0908
NA ORB1920-PO-0839
NA ORB1920-PO-0839
RS-3 M AND Disso 1 M & 3 M ORB1819-PO-2128
NA ORB1920-PO-1062
NA ORB1920-PO-1062
NA NA
1 Vial -- 2 mg ORB1920-PO-796
NA NA
System I and System XI ORB1920-PO-796
01 VIAL-100MG/VIAL ORB1920-PR-1116
NA NA
NA NA
NA NA
NA NA
Qty:05gm ORB1920-Po-1098
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
NA ORB1920-PO-1060
FOR AMT ORB920-PO-796
For API AMT AND Peptide Mapping Ve ORB920-PO-796
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-1112
NA ORB1920-PO-0727
50 mg
50 Mg NA Dinesh
10mL fill _RLD's APL/84/2019 Hiren Patel
5mL fill_RLD's APL/84/2019 Hiren Patel
5mL fill _RLD's APL/84/2019 Hiren Patel
Additional qty orb1819-po-2128
orb1819-po-2128
orb1819-po-2128
orb1819-po-2128
orb1819-po-2128
NA ORB1920-PO-1138 Amit Dombe
Info
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approval Pending
Approval Pending
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approval Pending
Approval Pending but Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approved & Printed
Approval Pending
M. Srihari / Sindhu Sagar Gupta
AMV - Quality Control
Alembic Pharmaceuticals Ltd.
Formulation Unit-III,
Survey no. 843, Vill - Karakhadi, Tal - Padra,
Dist. Vadodara 391450, Gujarat (India)
M. +91 9301053315, Ext - 2594

NRGP

Uploaded by

Copyright:

Available Formats

NRGP

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

NRGP

Uploaded by

Copyright:

Available Formats

Date Particulars Department Initiated by

10/1/2019 NGP:ORB1920-NR-0699 AR OPHTHALMIC Ankitha

Particulars Units Quantity

You might also like